More Quality Time

Investment Deck

Stem Cell Treatments are the future of medicine

Today, over 490 clinical trials employ bone marrow stem cells.
clinicaltrials.gov

Future generations will have access to their

young stem cells

Cord Blood Banking is

becoming more and
more commonplace.
Already millions of
Cord Blood Units are
being stored in over
500 specialized banks.

But stem cell health declines with age

and as we run out, the body loses its regenerative potential.

Stem cells that repair blood and vasculature, produced in the bone marrow, are found
circulating in the blood. The number of these circulating stem cells declines with age.
The number of circulating stem cells is predictive of lifespan in elderly individuals.
Aging Cell. 2006 Dec;5(6):495-503.
Biogerontology. 2005;6(3):185-92
Exp Gerontol. 2012 May;47(5):394-400

Rejuvenating mice with stem cells works

A single young stem cell transplant can extend mouse lifespan by 5%.
Front Genet. 2013 Aug 7;4:144.

For current adult generations to benefit,

we need to act now
The number and quality of our stem cells
decline with age, as do the systems they
replenish.
Stem cell therapies that extend lifespan
will become increasingly available in the
next decades. However, people without
access to their young stem cells will be the
last to benefit from these treatments.
By storing their young stem cells today,
people can have early access to lifeextending therapies in the years ahead.

We enable people to take the first step in

rejuvenation therapy today
Forever Labs facilitates the storage of
people's young stem cells to rejuvenate
their future self.
We have expertise in stem cell science,
orthopedic surgery, clinical operations,
administration, sales and marketing, IT,
and regulatory compliance.
We contract a FDA-complaint biorepository for cryogenic storage.
We started Forever Labs so we could treat
ourselves to live longer, because aging sucks.

The Forever Labs Procedure

Step 1. The stem cells are collected.

The out-patient procedure is performed

under local anesthetic. It takes 15 minutes
and can be done in a clinic.

Step 2. The stem cells are frozen.

The customers stem cells are stored in a

clinical grade bio-depository until they are
needed.

Life Extension as a Business

Successful rejuvenation
technology will likely be a major
component of future GDP.

is positioning itself strategically by building

early adopter relationships and revenue with the very first viable
interventions and therapies.

Our Opportunity
Comparables

Cord blood banking, U.S. 2013: 102K procedures, $300M revenue.

Vision correction surgery, U.S. 2015: 1M procedures, $1.2B revenue.

Market

4.3M in the U.S. between the ages of 25-54 earn $200k or more.
1% U.S. market capture and 10 years storage equates to $258M of revenue.

Valuable Customer Relationship

Individuals that do not have their young cells will have less options for
rejuvenation therapy. We enable people to start rejuvenation therapy today.
We will leverage our relationship with these valuable early-adoption customers
to build partnerships, advance the science of rejuvenation therapy, and to bring
new treatments to market.

The Forever Labs Team

Mark Katakowski, PhD
President

Laith Farjo, MD
Chief Medical Officer

Steven Clausnitzer
Chief Executive Officer

Edward Cibor
Chief Management Officer

Benjamin Buller, PhD

Chief Scientific Officer

Michael Elfassy
Chief Technology Officer

Mark is a funded staff scientist at Henry Ford

Hospital, Detroit. He has over 15 years experience in
stem cell therapy with a focus on neurological
disease. Mark has over 40 scientific publications
ranging from theoretical physics to cancer therapy.

Steven has over 15 years of award-winning sales

and team leadership at Fortune 500 companies. He
has extensive experience in strategic business
development and customer acquisition and
developed the Spend With Purpose Card for AMEX.

Ben is a funded staff scientist at Henry Ford

Hospital, Detroit. He has over 10 years experience in
stem cell therapy with a focus on neurological and
age-related disease. Ben has lobbied the U.S.
Congress on behalf of the American Heart
Association.

Colleen Ramirez, RN, CASC

Compliance Manager

Colleen is a 19 year veteran of the healthcare

industry and has substantial experience in many
clinical operational roles. She specializes in
ambulatory surgical center development and
operations and has successfully opened 5 ASCs.

Laith is a specialist in advanced arthroscopic surgery.

He has served as CEO of a surgical center, co-founded
a medical brace company, and developed IP for
surgical procedures. Laith was Hour Detroit
Magazine's Top 10 Doctor for 2012-2015.

Edward is an expert in regulatory navigation and

staffing, with over 10 years experience as a
compliance officer and project manager executing IT
projects for clients ranging from General Motors to
USA TACOM Life Cycle Management Command.

Michael is Regional Director for a digital branding and

advertising company. Michael has a BEng in Computer
and Electrical Engineering from McGill and a MBA
from HEC Montreal. He has over 10 years experience
working for digital marketing firms.

Finances
Where We Are At
Weve launched March 1, 2016 using funds from friends and family, and weve
immediately started generating revenues from sales. Multiple people are
already flying in from across the country, and we have just barely started.
In principle we are capable of maintaining and growing our operations purely
based on revenue from sales.
Funding
Forever Labs has the potential to become a leader in the life extension space,
and we are looking for angel and seed investors who believe in our vision to
bring workable interventions to market right now. In this spirit we are raising a
standard Silicon Valley style seed round from qualified investors. Please contact
us at:

info@foreverlabs.co

Forever Labs: Appendix

Marketing Forever Labs

Our Marketing Strategy

Our initial customers are coming from word of

mouth, social media marketing, and partnerships
with leading life extension companies and
communities.
In addition were also pursuing the following strategies:
Arthrex Physician Network
Were leveraging the national Arthrex physician network to
onboard orthopedics as credentialed Forever Labs
physicians, to offer storage to people who already receive
marrow procedures.
Boutique Medical Networks
Target exclusive healthcare networks such as MDVIP that
seek to differentiate from ordinary primary care practices.
Internet and Media
Search engine advertising, Twitter, and the Forever Labs
blog. Leverage contacts at media outlets.
Physical Materials
Brochures placed in physicians offices and waiting rooms.
Ads and articles in magazines that serve our target market.

Example Demographic Targeting: Hour

Detroit targets 389,812 affluent consumers
in high reader pass-along venues
throughout the area.

Sales Partnership
Arthrex/Forever Labs Partnership
Forever Labs has an agreement with Arthrex to use
their Arthrex Angel System for isolation of bone
marrow stem cells. Arthrex promotes Forever Labs to
their Physician network.

Strategic Benefits
Forever Labs gets competitive pricing for kits.
Arthrex recommends the Forever Labs to their
surgeons.
Patients can store stem cells that are already being
harvested in orthopedic procedures.
Surgeons get an additional revenue stream for
procedures they are already doing.

My patients are already asking me if they can store their stem cells
Tom Durick, MD, Oakland CA

Competition
Forever Labs will be the leader in treatments for aging with a customer experience that is
second to none. Our first-to-market position and execution will be our strongest advantage.
Allure Medical Spa; Livonia, MI, USA: Adipose-derived stem cell therapy for a variety of
treatments including joint repair, hair restoration, erectile dysfunction, and stroke recovery.
Cells administered immediately following isolation. Cryogenic storage is offered. Cost of
treatment is $6,000 to $10,500. Only uses adipose stem cells.
StemGenex; La Jolla, CA, USA: Adipose-derived stem cell therapy for a variety of treatments
including osteoarthritis, diabetes, multiple sclerosis, and Parkinson's disease. Only uses
adipose stem cells, but has quality concierge service.
Stem Cell Institute, Panama City, Panama: Adipose, bone marrow, and cord blood stem
cells for treatment of autism, cerebral palsy, heart failure, multiple sclerosis, osteoarthritis,
and more. No cryogenic freezing or treatment of aging.
Regenexx; Broomfield, CO, USA: Bone marrow stem cells for osteoarthritis, joint injuries
and spine conditions. 16k procedures reported to date. Cryogenic freezing in the Cayman
Islands for Regenexx procedures only. No treatment of aging.
Celltex Therapeutics; Houston, TX, USA: Adipose stem cells for treatment of several
diseases including osteoarthritis, Parkinsons, and Multiple Sclerosis. Celltex expands the cells
in the U.S. but offers treatment in Mexico. Cost of treatment is $6,500 for extraction and
$4,000 to $13,000 for treatment.

Our Advantage
Intellectual Property

Forever Labs is seeking patent protection for processes that Dr. Katakowski and Dr. Buller
have developed to improve isolation, storage, and reintroduction of bone marrow stem cells.
We are utilizing techniques now to enhance the recovery of stem cells at a later date.

Strategic Partnership

Arthrex, a leading global provider of orthobiologic products, recommends the Forever Labs
procedure to surgeons that employ Arthrex Angel System for isolation of stem cells in
orthopedic procedures. Patients are offered the option to bank cells at the time of surgery.
Surgeons get an additional revenue stream, and this helps Arthrex market their system.

Advanced Product Pipeline

Our expertise puts us at the cutting-edge of aging therapy, which enables us to aggressively
develop products and services.
Our next major product will include the isolation and storage of a customers young
circulating exosomes to be transplanted to their aged self.

Expertise and Execution

Our first-to-market position and our professional and scientific experience enables us to
build a brand that is second to none.

Projections (Y1-Y5)
60000

Revenue

$90,000,000

Profit

$80,000,000

50000

Procedures

Revenue, Profit

$70,000,000

40000

$60,000,000
$50,000,000

30000

$40,000,000
20000

$30,000,000
$20,000,000

Procedures Performed

$100,000,000

10000

$10,000,000
$0

Year 1

Service Projections

Year 2

Year 3

Year 4

Year 5

Year 1

Year 2

Year 3

Year 4

Year 5

14

26

35

Total Procedures

446

2520

7200

15680

24640

Storage

446

2966

10166

25846

50486

36

70

150

280

440

Regional Locations

Credentialed Physicians

Our First Market

Ann Arbor, Michigan

We selected Ann Arbor, Michigan as our initial

market due to its attractive population
demographics and our professional and social
contacts.
Home to the University of Michigan, the UofM
medical school, three hospitals, and many tech
and biotech businesses that include Google,
Expedia, and Johnson & Johnsons Healthmedia,
Ann Arbor is an affluent, well-educated, and
diverse community.
Population of 115k (73% white, 8% black, 14%
Asian, 5% multiracial/other). 54k between 20 and
45 years old (our target market).
69% are employed in healthcare, education, or
scientific or technical services vs. 31% statewide.
30% of households earn $100k+ vs. 18%
statewide. 8% earn $200k+ vs. 3% statewide.

Ann Arbor, Michigan is an ideal target

market with coverage that includes Metro
Detroit and Toledo.

Our Second Market

Research Triangle, North Carolina

We selected the Research Triangle of

Piedmont of North Carolina as our second
market due to its attractive population
demographics and our professional and social
contacts.
Home to North Carolina State University, Duke
University, University of North Carolina at
Chapel Hill, the cities of Raleigh and Durham,
and the towns of Cary and Chapel Hill, the
Triangle is an affluent, well-educated, and
diverse community.
Population of 534k (55% white, 27% black, 4%
Asian, 14% multiracial/other). 220k between
20 and 45 years old (our target market).
40% are employed in healthcare, education, or
scientific or technical services vs. 31%
statewide. 24% of households earn $100k+ vs.
17% statewide. 7% earn $200k+ vs. 3%
statewide.

North Carolinas Research Triangle is

an ideal target market with coverage
that includes several universities, the
cities of Raleigh and Durham, and the
towns of Cary and Chapel Hill.

Our Third Market

San Francisco, California
We selected Ann Arbor, Michigan and the
Piedmont of North Carolina based upon
demographics and our initial resources. San
Francisco is our third market for demographic
reasons that do not require elucidation.
We already have clients flying to Michigan
from the Bay Area to have the procedure
preformed.
In addition, we have dozens of prospects that
have instructed us to tell them when we are
operational in San Francisco.
Other attractive markets such as New York,
Los Angeles, Washington D.C., Chicago, and
Miami will follow.

Market Survey Results

We introduced members of our target demographic to our website (www.foreverlabs.co) and
then asked them to take a short survey gauging their interest level and perception of the
Forever Labs procedure.
70 respondents chose to take our optional survey. These respondents are all located in the
United States, over 30 years of age, and earn over $75,000 USD/yr.

57.6% of respondents were somewhat or very interested in the procedure. For those that were
somewhat interested, a better understanding of the medical and scientific benefit would most
likely increase their interest.
The respondents were asked what they expected our procedure to cost. The mean average
expected price was $5,392 USD, with a median average expected price of $5,000 USD.

Additional Research Support

Scientific support of the Forever Labs procedure:
http://www.foreverlabs.co/research
Additional scientific and clinical data can be provided upon request.